Literature DB >> 10582899

High-level aminoglycoside resistance in the beta-hemolytic group G Streptococcus isolate BM2721.

M Galimand1, T Lambert, G Gerbaud, P Courvalin.   

Abstract

The beta-hemolytic group G Streptococcus clinical isolate BM2721 was resistant to high levels of aminoglycosides by synthesis of AAC(6')-APH(2"), APH(3')-III, and ANT(6) modifying enzymes. The corresponding genes were found to be adjacent as the result of a recombination event between Tn4001 and Tn5405, two transposons originating in staphylococci.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10582899      PMCID： PMC89604          DOI： 10.1128/AAC.43.12.3008

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics.

Authors:  E STEERS; E L FOLTZ; B S GRAVES
Journal:  Antibiot Chemother (Northfield)       Date:  1959-05

2.  Chromosome- and plasmid-mediated gentamicin resistance in Staphylococcus aureus encoded by Tn4001.

Authors:  M T Gillespie; B R Lyon; L J Messerotti; R A Skurray
Journal:  J Med Microbiol       Date:  1987-09       Impact factor: 2.472

3.  Mapping the regions carrying the three contiguous antibiotic resistance genes aadE, sat4, and aphA-3 in the genomes of staphylococci.

Authors:  A Derbise; S Aubert; N El Solh
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

4.  Nucleotide sequence analysis of IS256 from the Staphylococcus aureus gentamicin-tobramycin-kanamycin-resistance transposon Tn4001.

Authors:  M E Byrne; D A Rouch; R A Skurray
Journal:  Gene       Date:  1989-09-30       Impact factor: 3.688

5.  The aacA-aphD gentamicin and kanamycin resistance determinant of Tn4001 from Staphylococcus aureus: expression and nucleotide sequence analysis.

Authors:  D A Rouch; M E Byrne; Y C Kong; R A Skurray
Journal:  J Gen Microbiol       Date:  1987-11

6.  In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci.

Authors:  K Lam; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

7.  Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5"-aminoglycoside phosphotransferase type III.

Authors:  P Trieu-Cuot; P Courvalin
Journal:  Gene       Date:  1983-09       Impact factor: 3.688

8.  High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B).

Authors:  A Buu-Hoï; C Le Bouguenec; T Horaud
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

9.  Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes.

Authors:  A E Jacob; S J Hobbs
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205
View more
  3 in total

1.  Multicenter study on spreading of the tet(M) gene in tetracycline-resistant Streptococcus group G and C isolates in Argentina.

Authors:  P E Jeric; H Lopardo; P Vidal; S Arduino; A Fernandez; B E Orman; D O Sordelli; D Centrón
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Aminoglycoside resistance genes aph(2")-Ib and aac(6')-Im detected together in strains of both Escherichia coli and Enterococcus faecium.

Authors:  J W Chow; V Kak; I You; S J Kao; J Petrin; D B Clewell; S A Lerner; G H Miller; K J Shaw
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

3.  Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina.

Authors:  Horacio A Lopardo; Patricia Vidal; Monica Sparo; Paola Jeric; Daniela Centron; Richard R Facklam; Hugo Paganini; N Gaston Pagniez; Marguerite Lovgren; Bernard Beall
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.